Loading company…
Tianjin Hopson Biotechnology researches synthetic biology technologies and provides healthcare services.
Tianjin Hopson Biotechnology Co., Ltd. researches synthetic biology, including gene element discovery, genome editing, protein expression, and omics analysis, and provides healthcare services. Founded in 2023, the company is based in Tianjin, China. In July 2025, it closed a Pre-series A funding round led by Bohai Securities, with Haihe River Industry Fund and Tianjin Kechuang participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Tianjin Hopson Biotechnology Co., Ltd? This is my company